TESARO Stock Price, News & Analysis (NASDAQ:TSRO)

$60.74 -0.15 (-0.25 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$60.74
Today's Range$59.75 - $61.99
52-Week Range$55.02 - $190.40
Volume623,597 shs
Average Volume1.16 million shs
Market Capitalization$3.28 billion
P/E Ratio-7.21
Dividend YieldN/A
Beta1.25

About TESARO (NASDAQ:TSRO)

TESARO logoTESARO, Inc. is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform. Rolapitant is a potent and long-acting neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Niraparib is an orally active and potent poly (adenosine diphosphate (ADP)-ribose) polymerase inhibitor. It has various ongoing clinical trials evaluating niraparib for the treatment of ovarian or breast cancers. It has initiated a Phase I, dose escalation study for its first immuno-oncology antibody, TSR-042, which targets Programmed cell death protein 1. It has commenced pre-clinical research for its antibody candidate targeting Lymphocyte-activation gene-3 andTSR-033. It has commenced a Phase I clinical trial of TSR-042.

Receive TSRO News and Ratings via Email

Sign-up to receive the latest news and ratings for TSRO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryBiotechnology
SectorHealthcare
SymbolNASDAQ:TSRO
CUSIP88156910
Phone+1-339-9700900

Debt

Debt-to-Equity Ratio0.34%
Current Ratio4.73%
Quick Ratio4.35%

Price-To-Earnings

Trailing P/E Ratio-7.20521945432978
Forward P/E Ratio-7.41
P/E GrowthN/A

Sales & Book Value

Annual Sales$44.82 million
Price / Sales73.70
Cash FlowN/A
Price / CashN/A
Book Value$11.44 per share
Price / Book5.31

Profitability

Trailing EPS($8.43)
Net Income$-387,470,000.00
Net Margins-251.22%
Return on Equity-93.39%
Return on Assets-61.53%

Miscellaneous

Employees446
Outstanding Shares54,380,000

TESARO (NASDAQ:TSRO) Frequently Asked Questions

What is TESARO's stock symbol?

TESARO trades on the NASDAQ under the ticker symbol "TSRO."

How were TESARO's earnings last quarter?

TESARO Inc (NASDAQ:TSRO) released its quarterly earnings data on Tuesday, November, 7th. The biopharmaceutical company reported ($0.47) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($1.16) by $0.69. The biopharmaceutical company had revenue of $142.77 million for the quarter, compared to the consensus estimate of $130.57 million. TESARO had a negative net margin of 251.22% and a negative return on equity of 93.39%. The company's quarterly revenue was up 740.3% on a year-over-year basis. During the same period in the previous year, the company earned ($1.72) earnings per share. View TESARO's Earnings History.

When will TESARO make its next earnings announcement?

TESARO is scheduled to release their next quarterly earnings announcement on Tuesday, February, 27th 2018. View Earnings Estimates for TESARO.

Where is TESARO's stock going? Where will TESARO's stock price be in 2018?

23 brokers have issued 12 month price objectives for TESARO's stock. Their predictions range from $65.00 to $236.00. On average, they expect TESARO's share price to reach $147.30 in the next year. View Analyst Ratings for TESARO.

What are Wall Street analysts saying about TESARO stock?

Here are some recent quotes from research analysts about TESARO stock:

  • 1. HC Wainwright analysts commented, "Updates to Varubi’s Label; Reiterate Buy and $158 Price Target Prescribing information update, no products being recalled. After the close on January 12, TESARO announced that it has updated the Varubi injectable emulsion package insert in collaboration with the FDA. The changes to the label include modifications to the Contradictions, Warnings and Precuations, and Adverse Reactions section to inclde anaphylaxis, anaphylactic shock and other serious hypersensitivity reactions associated with the use of Varubi injectable emulsion. The company indicated that anaphylaxis, anaphylactic shock and other hypersensitivity reactions have been reported in the postmarketing setting, with some cases requiring hospitalization. These side effects were noted during or soon after the infusion of Varubi, with most reactions observed during the first few minutes of administration." (1/12/2018)
  • 2. According to Zacks Investment Research, "Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer and other cancer indications, and Niraparib, an orally active and potent poly (ADP-ribose) polymerase inhibitor for the treatment of patients with solid tumors. Tesaro, Inc. is based in Waltham, Massachusetts. " (1/11/2018)
  • 3. Cann analysts commented, "Total Q3 revenue of $142.8 million included a $100 million upfront payment. Net of the upfront payment, revenue was 27.4% higher than our estimated $33.6 million due to stronger than estimated Zejula sales. Total operating expenses of $164.9 million were 3.0% lower than our estimated $170.0 million due to lower than estimated R&D expense. Due to the combination of higher than estimated revenue and slightly lower expenses, Tesaro lost $0.47 per share compared to our estimated loss per share of $2.56." (11/7/2017)
  • 4. FBR & Co analysts commented, "We received our first data snapshot from the RX-3117 Phase 2a study in advanced muscle invasive bladder cancer at ASCO this weekend with data coming from 10 patients in stage 1 of the study. The study achieved the predefined efficacy criteria (two of ten patients achieving a PFS of at least four months or a partial or complete tumor response), where 22% of patients have experienced PFS for a minimum of six months. One of the two aforementioned patients is still on study, achieving 175 days of stable disease. While only stage 1 of this study, we believe it is important to point out that patients who have reached this stage of disease are usually limited to palliative or best supportive care." (6/5/2017)
  • 5. Cowen Inc analysts commented, "TSRO reported 1Q financials, provided a pipeline update and commented on Zejula’s." (5/11/2017)

Who are some of TESARO's key competitors?

Who are TESARO's key executives?

TESARO's management team includes the folowing people:

  • David M. Mott, Independent Chairman of the Board (Age 51)
  • Mary Lynne Hedley Ph.D., President, Chief Operating Officer, Director (Age 54)
  • Leon O. Moulder Jr., Chief Executive Officer, Director (Age 59)
  • Timothy R. Pearson, Chief Financial Officer, Executive Vice President, Principal Accounting Officer (Age 49)
  • Jeffrey H. Hanke Ph.D., Executive Vice President - Research and Development, Chief Scientific Officer (Age 59)
  • Joseph L. Farmer, Senior Vice President, General Counsel, Secretary (Age 45)
  • Grant C. Bogle, Senior Vice President, Chief Commercial Officer (Age 59)
  • Martin H. Huber M.D., Senior Vice President and Chief Medical Officer (Age 57)
  • Lawrence M. Alleva, Independent Director (Age 67)
  • James O. Armitage M.D., Independent Director (Age 70)

Who owns TESARO stock?

TESARO's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.48%), TimesSquare Capital Management LLC (1.58%), Rock Springs Capital Management LP (1.01%), Franklin Resources Inc. (0.97%), Alliancebernstein L.P. (0.94%) and Bank of New York Mellon Corp (0.88%). Company insiders that own TESARO stock include Arnold L Oronsky, Edward C English, Enterprise Associates 13 L New, Grant C Bogle, James O Armitage, Jeffrey H Hanke, Martin H Jr Huber, Mary Lynne Hedley and Orlando Oliveira. View Institutional Ownership Trends for TESARO.

Who sold TESARO stock? Who is selling TESARO stock?

TESARO's stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Perceptive Advisors LLC, Fred Alger Management Inc., Teachers Advisors LLC, Sectoral Asset Management Inc, Amundi Pioneer Asset Management Inc., Bank of New York Mellon Corp and TIAA CREF Investment Management LLC. Company insiders that have sold TESARO company stock in the last year include Edward C English, Grant C Bogle, James O Armitage, Martin H Jr Huber, Mary Lynne Hedley and Orlando Oliveira. View Insider Buying and Selling for TESARO.

Who bought TESARO stock? Who is buying TESARO stock?

TESARO's stock was purchased by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Renaissance Technologies LLC, BlackRock Inc., Element Capital Management LLC, Millennium Management LLC, Spark Investment Management LLC, NF Trinity Capital Hong Kong Ltd and Alliancebernstein L.P.. Company insiders that have bought TESARO stock in the last two years include Arnold L Oronsky and Enterprise Associates 13 L New. View Insider Buying and Selling for TESARO.

How do I buy TESARO stock?

Shares of TESARO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is TESARO's stock price today?

One share of TESARO stock can currently be purchased for approximately $60.74.

How big of a company is TESARO?

TESARO has a market capitalization of $3.28 billion and generates $44.82 million in revenue each year. The biopharmaceutical company earns $-387,470,000.00 in net income (profit) each year or ($8.43) on an earnings per share basis. TESARO employs 446 workers across the globe.

How can I contact TESARO?

TESARO's mailing address is 1000 Winter St Ste 3300, WALTHAM, MA 02451-1230, United States. The biopharmaceutical company can be reached via phone at +1-339-9700900.


MarketBeat Community Rating for TESARO (TSRO)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  459 (Vote Outperform)
Underperform Votes:  280 (Vote Underperform)
Total Votes:  739
MarketBeat's community ratings are surveys of what our community members think about TESARO and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

TESARO (NASDAQ:TSRO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.632.582.582.64
Ratings Breakdown: 0 Sell Rating(s)
9 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $147.30$148.74$161.00$175.38
Price Target Upside: 137.55% upside134.23% upside87.43% upside54.03% upside

TESARO (NASDAQ:TSRO) Consensus Price Target History

Price Target History for TESARO (NASDAQ:TSRO)

TESARO (NASDAQ:TSRO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/22/2018Evercore ISIUpgradeIn-Line -> Outperform$88.00HighView Rating Details
1/18/2018Piper Jaffray CompaniesReiterated RatingHold$65.00LowView Rating Details
1/18/2018Credit Suisse GroupReiterated RatingOutperform -> Outperform$190.00 -> $150.00HighView Rating Details
1/16/2018Morgan StanleyLower Price TargetOverweight$165.00 -> $156.00HighView Rating Details
1/12/2018HC WainwrightReiterated RatingBuy$158.00HighView Rating Details
1/2/2018CowenLower Price TargetMarket Perform$125.00 -> $80.00LowView Rating Details
12/20/2017CitigroupReiterated RatingBuy -> Buy$216.00 -> $135.00LowView Rating Details
11/28/2017ArgusSet Price TargetBuy$154.00LowView Rating Details
11/15/2017Leerink SwannUpgradeMarket Perform -> OutperformN/AView Rating Details
11/10/2017SunTrust BanksReiterated RatingBuy$160.00N/AView Rating Details
11/10/2017Robert W. BairdReiterated RatingHold$120.00N/AView Rating Details
11/9/2017Lake Street CapitalReiterated RatingBuy$143.00N/AView Rating Details
11/7/2017CannReiterated RatingBuy$199.00N/AView Rating Details
11/3/2017Jefferies GroupReiterated RatingHold$124.00N/AView Rating Details
10/23/2017BarclaysInitiated CoverageEqual Weight -> Equal Weight$135.00N/AView Rating Details
9/14/2017Royal Bank of CanadaInitiated CoverageSector Perform$120.00MediumView Rating Details
9/11/2017WedbushReiterated RatingOutperform$160.00LowView Rating Details
9/10/2017OppenheimerReiterated RatingBuy$199.00LowView Rating Details
8/20/2017Wells Fargo & CoReiterated RatingOutperformHighView Rating Details
7/14/2017Janney Montgomery ScottReiterated RatingNeutralLowView Rating Details
7/7/2017GabelliInitiated CoverageBuy$175.00HighView Rating Details
6/20/2017Raymond James FinancialReiterated RatingMarket PerformMediumView Rating Details
6/20/2017Bank of AmericaReiterated RatingBuy$154.00HighView Rating Details
6/5/2017FBR & CoLower Price TargetMkt Perform -> Mkt Perform$200.00 -> $195.00HighView Rating Details
8/5/2016MizuhoLower Price TargetBuy$100.00 -> $94.00N/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

TESARO (NASDAQ:TSRO) Earnings History and Estimates Chart

Earnings by Quarter for TESARO (NASDAQ:TSRO)

TESARO (NASDAQ TSRO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018($2.35)N/AView Earnings Details
11/7/2017Q3 2017($1.16)($0.47)$130.57 million$142.77 millionViewN/AView Earnings Details
8/8/2017Q2 2017($2.52)($2.82)$18.61 million$29.50 millionViewListenView Earnings Details
5/9/2017Q1 2017($2.26)($2.55)$3.84 million$3.10 millionViewListenView Earnings Details
2/28/2017Q4 2016($1.96)($2.60)$5.60 million$4.23 millionViewN/AView Earnings Details
11/3/2016Q3($1.92)($1.98)$4.39 million$3.73 millionViewN/AView Earnings Details
8/4/2016Q2 2016($1.69)($1.28)$10.49 million$36.56 millionViewN/AView Earnings Details
5/5/2016Q1($1.69)($2.22)$2.48 million$0.31 millionViewN/AView Earnings Details
2/25/2016Q4($1.63)($1.89)$3.45 million$0.23 millionViewListenView Earnings Details
10/29/2015Q315($1.52)($1.66)$0.09 millionViewListenView Earnings Details
8/6/2015Q215($1.14)($1.51)ViewListenView Earnings Details
4/30/2015Q115($1.12)($1.30)ViewListenView Earnings Details
2/19/2015Q414($1.03)($1.33)ViewListenView Earnings Details
11/5/2014Q314($1.04)($1.01)ViewN/AView Earnings Details
7/24/2014Q214($0.87)($1.03)ViewN/AView Earnings Details
4/30/2014Q114($1.06)($1.43)ViewN/AView Earnings Details
2/19/2014Q413($0.78)($0.72)ViewN/AView Earnings Details
11/7/2013Q313($0.69)($0.88)ViewN/AView Earnings Details
7/25/2013Q2 2013($0.63)($0.67)ViewN/AView Earnings Details
4/25/2013Q1 2013($0.62)($0.66)ViewN/AView Earnings Details
2/14/2013Q4 2012($0.65)($15.41)ViewN/AView Earnings Details
10/25/2012($0.55)($0.52)ViewN/AView Earnings Details
7/26/2012($0.55)($4.11)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

TESARO (NASDAQ:TSRO) Earnings Estimates

2018 EPS Consensus Estimate: ($7.13)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184($2.39)($1.35)($2.01)
Q2 20184($2.27)($0.93)($1.75)
Q3 20184($2.15)($0.94)($1.73)
Q4 20184($2.03)($1.17)($1.65)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for TESARO (NASDAQ:TSRO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

TESARO (NASDAQ TSRO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 40.50%
Insider Trades by Quarter for TESARO (NASDAQ:TSRO)
Institutional Ownership by Quarter for TESARO (NASDAQ:TSRO)

TESARO (NASDAQ TSRO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2017Martin H Jr. HuberSVPSell829$85.24$70,663.968,101View SEC Filing  
9/22/2017Martin H Jr. HuberSVPSell592$118.60$70,211.206,943View SEC Filing  
9/18/2017James O ArmitageDirectorSell10,000$117.13$1,171,300.0010,000View SEC Filing  
9/6/2017Edward C EnglishVPSell10,862$134.92$1,465,501.046,258View SEC Filing  
9/5/2017Orlando OliveiraSVPSell71$132.66$9,418.866,626View SEC Filing  
9/1/2017Grant C. BogleVPSell14,167$135.00$1,912,545.00View SEC Filing  
6/6/2017Edward C EnglishVPSell8,500$138.65$1,178,525.005,396View SEC Filing  
4/3/2017Martin H Jr. HuberSVPSell829$153.02$126,853.586,522View SEC Filing  
3/6/2017Edward C EnglishVPSell10,000$178.06$1,780,600.005,396View SEC Filing  
3/2/2017Edward C EnglishVPSell229$177.61$40,672.69625View SEC Filing  
3/2/2017Grant C. BogleSVPSell1,447$177.61$257,001.67View SEC Filing  
3/2/2017Mary Lynne HedleyCOOSell3,927$177.61$697,474.4710,000View SEC Filing  
1/3/2017Martin H. Jr. HuberSVPSell190$136.26$25,889.40View SEC Filing  
11/2/2016Martin H Jr. HuberSVPSell327$121.29$39,661.831,842View SEC Filing  
9/22/2016Martin H Jr. HuberSVPSell408$108.12$44,112.961,250View SEC Filing  
9/8/2016Edward C EnglishVPSell7,000$88.54$619,780.003,500View SEC Filing  
8/30/2016Jeffrey H HankeVPSell29,166$86.04$2,509,442.6429,166View SEC Filing  
6/30/2016Jeffrey H HankeVPSell12,500$74.35$929,375.0012,500View SEC Filing  
6/10/2016Edward C EnglishVPSell7,000$40.75$285,250.003,500View SEC Filing  
3/18/2016Arnold L OronskyDirectorBuy142,085$35.19$4,999,971.152,479View SEC Filing  
3/18/2016Enterprise Associates 13 L NewMajor ShareholderBuy710,429$35.19$24,999,996.51View SEC Filing  
3/10/2016Edward C EnglishVPSell7,000$43.71$305,970.003,500View SEC Filing  
12/10/2015Edward C. EnglishVPSell17,000$50.19$853,230.00View SEC Filing  
9/8/2015James O ArmitageDirectorBuy500$54.63$27,315.00View SEC Filing  
12/12/2014James O ArmitageDirectorBuy1,000$38.16$38,160.00View SEC Filing  
9/29/2014Lawrence M AllevaDirectorBuy1,100$26.17$28,787.00View SEC Filing  
7/31/2013Lawrence M AllevaDirectorBuy1,449$34.33$49,744.17View SEC Filing  
6/5/2013Peter J BarrisMajor ShareholderSell3,583$39.00$139,737.00View SEC Filing  
4/30/2013Lawrence M AllevaDirectorBuy1,050$28.10$29,505.00View SEC Filing  
11/1/2012Lawrence M AllevaDirectorBuy3,240$15.45$50,058.00View SEC Filing  
8/30/2012Leon O Moulder JrCEOBuy10,000$11.69$116,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

TESARO (NASDAQ TSRO) News Headlines

Source:
DateHeadline
TSRO EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)TSRO EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)
finance.yahoo.com - February 23 at 5:22 PM
PLG Reminds Investors of Important March 19, 2018 Lead Plaintiff Deadline in Class Action- TSROPLG Reminds Investors of Important March 19, 2018 Lead Plaintiff Deadline in Class Action- TSRO
finance.yahoo.com - February 23 at 5:22 PM
EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TESARO, Inc. - TSROEQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TESARO, Inc. - TSRO
www.prnewswire.com - February 23 at 4:10 PM
TESARO (TSRO) Upgraded at Evercore ISITESARO (TSRO) Upgraded at Evercore ISI
www.americanbankingnews.com - February 23 at 12:14 AM
DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against TESARO, Inc. And Encourages Investors with Losses Exceeding $100,000 to Contact the FirmDEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against TESARO, Inc. And Encourages Investors with Losses Exceeding $100,000 to Contact the Firm
finance.yahoo.com - February 22 at 5:25 PM
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for TESARO, Inc. Shareholders - GlobeNewswire (press release)Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for TESARO, Inc. Shareholders - GlobeNewswire (press release)
globenewswire.com - February 22 at 8:23 AM
TESARO Inc (TSRO) Given Consensus Recommendation of "Hold" by BrokeragesTESARO Inc (TSRO) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 21 at 7:30 PM
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for TESARO, Inc. ShareholdersKessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for TESARO, Inc. Shareholders
finance.yahoo.com - February 21 at 5:26 PM
The Klein Law Firm Reminds Investors of a Class Action on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)The Klein Law Firm Reminds Investors of a Class Action on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)
finance.yahoo.com - February 21 at 5:26 PM
TESARO Inc (TSRO) Expected to Post Earnings of -$2.41 Per ShareTESARO Inc (TSRO) Expected to Post Earnings of -$2.41 Per Share
www.americanbankingnews.com - February 21 at 3:16 PM
Quotidian Technical Highlights on Selected Biotech Stocks -- Tesaro, Trevena, Vanda Pharma, and VerastemQuotidian Technical Highlights on Selected Biotech Stocks -- Tesaro, Trevena, Vanda Pharma, and Verastem
www.bizjournals.com - February 21 at 8:55 AM
DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Tesaro Incorporated To Contact The FirmDEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Tesaro Incorporated To Contact The Firm
finance.yahoo.com - February 20 at 5:20 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: March 19, 2018SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: March 19, 2018
finance.yahoo.com - February 20 at 5:20 PM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 - TSROEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 - TSRO
finance.yahoo.com - February 20 at 5:20 PM
Critical Review: TESARO (TSRO) and Vical (VICL)Critical Review: TESARO (TSRO) and Vical (VICL)
www.americanbankingnews.com - February 19 at 8:02 AM
TESARO (TSRO) to Release Quarterly Earnings on MondayTESARO (TSRO) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - February 19 at 4:44 AM
Research Report Identifies TESARO, Brunswick, Brooks Automation, Infinity Pharmaceuticals, Edison International, and Anthem with Renewed Outlook — Fundamental Analysis, Calculating Forward MovementResearch Report Identifies TESARO, Brunswick, Brooks Automation, Infinity Pharmaceuticals, Edison International, and Anthem with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
finance.yahoo.com - February 16 at 8:12 AM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 – TSROINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 – TSRO
finance.yahoo.com - February 15 at 5:25 PM
TSRO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)TSRO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)
finance.yahoo.com - February 15 at 5:25 PM
In The Spotlight: AnaptysBio - NasdaqIn The Spotlight: AnaptysBio - Nasdaq
www.nasdaq.com - February 15 at 7:16 AM
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Lawsuit Filed Against TESARO, Inc.Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Lawsuit Filed Against TESARO, Inc.
finance.yahoo.com - February 14 at 3:31 PM
The Klein Law Firm Notifies Investors of a Class Action Commenced on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)The Klein Law Firm Notifies Investors of a Class Action Commenced on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)
finance.yahoo.com - February 12 at 3:29 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline – TSROSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline – TSRO
finance.yahoo.com - February 10 at 3:31 PM
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Tesaro Incorporated (Nasdaq: TSRO) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Tesaro Incorporated (Nasdaq: TSRO) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
feeds.benzinga.com - February 10 at 12:24 PM
BidaskClub Downgrades TESARO (TSRO) to Strong SellBidaskClub Downgrades TESARO (TSRO) to Strong Sell
www.americanbankingnews.com - February 10 at 8:50 AM
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline – TSROSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline – TSRO
feeds.benzinga.com - February 10 at 8:36 AM
SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against TESARO, Inc. -- TSROSHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against TESARO, Inc. -- TSRO
finance.yahoo.com - February 9 at 3:36 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 - TSROSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 - TSRO
finance.yahoo.com - February 9 at 3:36 PM
DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against TESARO, Inc. And Encourages Investors with Losses Exceeding $100,000 to Contact the FirmDEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against TESARO, Inc. And Encourages Investors with Losses Exceeding $100,000 to Contact the Firm
finance.yahoo.com - February 9 at 3:36 PM
TESARO, Inc. Reminder: Important March 19, 2018 Lead Plaintiff Deadline in Class Action- TSROTESARO, Inc. Reminder: Important March 19, 2018 Lead Plaintiff Deadline in Class Action- TSRO
finance.yahoo.com - February 9 at 3:36 PM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 - TSROINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018 - TSRO
finance.yahoo.com - February 9 at 3:36 PM
TESARO Notice: Rosen Law Firm Announces Filing of Securities ... - GlobeNewswire (press release)TESARO Notice: Rosen Law Firm Announces Filing of Securities ... - GlobeNewswire (press release)
globenewswire.com - February 9 at 7:16 AM
TESARO Notice: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TESARO, Inc. – TSROTESARO Notice: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TESARO, Inc. – TSRO
finance.yahoo.com - February 9 at 7:16 AM
TSRO March 29th Options Begin Trading - NasdaqTSRO March 29th Options Begin Trading - Nasdaq
www.nasdaq.com - February 8 at 3:28 PM
TSRO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)TSRO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018 (TSRO)
finance.yahoo.com - February 8 at 3:28 PM
TSRO EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018TSRO EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tesaro, Inc. and a Lead Plaintiff Deadline of March 19, 2018
finance.yahoo.com - February 6 at 3:28 PM
The Klein Law Firm Reminds Investors that a Class Action Has Commenced on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018The Klein Law Firm Reminds Investors that a Class Action Has Commenced on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018
finance.yahoo.com - February 6 at 3:28 PM
Lawsuit for Investors in NASDAQ: TSRO shares against TESARO Inc announced by Shareholders Foundation - GlobeNewswire (press release)Lawsuit for Investors in NASDAQ: TSRO shares against TESARO Inc announced by Shareholders Foundation - GlobeNewswire (press release)
globenewswire.com - February 6 at 7:02 AM
$51.78 Million in Sales Expected for TESARO Inc (TSRO) This Quarter$51.78 Million in Sales Expected for TESARO Inc (TSRO) This Quarter
www.americanbankingnews.com - February 6 at 3:02 AM
Lawsuit for Investors in NASDAQ: TSRO shares against TESARO Inc announced by Shareholders FoundationLawsuit for Investors in NASDAQ: TSRO shares against TESARO Inc announced by Shareholders Foundation
feeds.benzinga.com - February 5 at 8:37 PM
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against TESARO, Inc. And Encourages Investors with Losses Exceeding $100,000 to Contact the FirmINVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against TESARO, Inc. And Encourages Investors with Losses Exceeding $100,000 to Contact the Firm
finance.yahoo.com - February 5 at 3:27 PM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: March 19, 2018SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: March 19, 2018
finance.yahoo.com - February 5 at 3:27 PM
Zacks: Analysts Expect TESARO Inc (TSRO) to Post -$2.41 Earnings Per ShareZacks: Analysts Expect TESARO Inc (TSRO) to Post -$2.41 Earnings Per Share
www.americanbankingnews.com - February 4 at 3:20 PM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of Commencement of a Class Action ... - Business Wire (press release)EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of Commencement of a Class Action ... - Business Wire (press release)
www.businesswire.com - February 4 at 7:09 AM
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesaro, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2018
finance.yahoo.com - February 3 at 7:07 AM
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Tesaro Incorporated Investors and Encourages Investors to Contact the Firm (TSRO)Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Tesaro Incorporated Investors and Encourages Investors to Contact the Firm (TSRO)
finance.yahoo.com - February 2 at 3:30 PM
The Klein Law Firm Announces a Class Action Commenced on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff ... - Business Wire (press release)The Klein Law Firm Announces a Class Action Commenced on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff ... - Business Wire (press release)
www.businesswire.com - February 2 at 7:07 AM
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Filed Against Tesaro, Inc. - TSROKessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Filed Against Tesaro, Inc. - TSRO
finance.yahoo.com - February 1 at 3:28 PM
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against TESARO, Inc.IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against TESARO, Inc.
finance.yahoo.com - February 1 at 7:16 AM
The Klein Law Firm Announces a Class Action Filed on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018The Klein Law Firm Announces a Class Action Filed on Behalf of Tesaro, Inc. Shareholders and a Lead Plaintiff Deadline of March 19, 2018
finance.yahoo.com - February 1 at 7:16 AM

SEC Filings

TESARO (NASDAQ:TSRO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

TESARO (NASDAQ:TSRO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

TESARO (NASDAQ TSRO) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.